presence of fetal distress are of more utility than coagulation profiles or Kleihauer-Betke screens, and when positive usually heralds a catastrophic outcome (10, 11) .
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Summary
Thrombomodulin (TM), a marker of endothelial cell damage, has been localized to the placental syncytiotrophoblast. A prospective cohort study of twenty-five pregnant women who were admitted with a clinical diagnosis of placental abruption was undertaken. Abruption was confirmed after delivery in eight cases (Group 1). Group 2 consisted of seventeen patients with no clinical or pathologic evidence of placental abruption after delivery. TM was significantly elevated in Group 1 (71.59 ± 5.35 vs. 48.29 ± 3.53 ng/ml, p = 0.001). The sensitivity and specificity of TM ≥ 60 ng/ml as a marker for abruption was 87.5 and 76.5%, respectively. In comparison, the sensitivity of an abnormal coagulation profile, maternal Kleihauer-Betke and ultrasound in patients with abruption was 0, 16.7 and 28.6%, respectively. TM is a highly sensitive and specific marker for acute placental abruption.
Introduction
Placental abruption complicates approximately 1% of pregnancies and is a major contributor to perinatal and maternal morbidity and mortality. Risk factors for abruption include advanced maternal age, smoking, hypertension, trauma, cocaine, the presence of an anomalous fetus, sudden uterine decompression and previous history of abruption (1, 2, 3) . Diagnostic difficulties remain and clinical symptomatology, such as unexplained back or abdominal pain and vaginal bleeding, is still the mainstay of diagnosis. However, antepartum vaginal bleeding is absent in 20-35% of cases. The diagnosis is not made until after delivery in 38% of cases (4) . Diagnostic tests such as the Kleihauer-Betke fetal red cell screen lack sensitivity and specificity (5) . Coagulopathy is rarely detected with a live fetus but may be present in 35-38% of cases with a dead fetus (1, 6) . The Ddimer latex agglutination slide test has been shown in one study to be a more sensitive marker than other laboratory measures of coagulation (sensitivity of 67% compared to less than 20% for thrombocytopenia, prolonged prothrombin time or hypofibrinogenemia) (7). Elevated maternal serum alpha-fetoprotein, which in the second trimester has been associated with a ten-fold risk of placental abruption, has wide fluctuations in the third trimester and is therefore not clinically useful (8) . Serum CA 125, which is released by the decidua, is also elevated in some cases of placental abruption but does not appear to be a sensitive marker (9) . Ultrasound can be used to diagnose large hematomas and those that have already calcified but is not useful in detecting acute bleeding. In the setting of blunt trauma, ultrasound and the evidence of placental abruption after delivery. The clinical characteristics of the groups are presented in Table 1 . None of the patients had clinical evidence of DIC before or after their delivery. There was no statistically significant difference in age, race, gravidity, parity or gestational age between the groups. No patients in Group 1 had urine toxicology positive for cocaine; there was one positive result in Group 2. TM was significantly greater in Group 1 (71.59 ± 5.35 vs. 48.29 ± 3.53 ng/ml, p = 0.001). The test results of the patients with abruption are presented in Table 2 .
Six patients had acute abruption at delivery. Defining TM ≥ 60 ng/ml as positive, (see Fig. 1 ), the sensitivity and specificity of TM as a marker for abruption were 87.5 and 76.5%, respectively. All patients with acute abruption had plasma TM greater than 60 ng/ml. The two patients with pathologically diagnosed chronic abruption were the only patients with ultrasonography showing retroplacental hematomas. One of these patients had a negative TM level of 47.8 ng/ml and the other a TM level of 61.3, a borderline value at the cut-off of the Receiver Operator Characteristic curve. In comparison, the sensitivity of an abnormal coagulation profile, maternal Kleihauer-Betke and ultrasound in Group 1 were 0, 16.7 and 28.6%, respectively (Table 3) . When the combination of TM and ultrasound was used, the sensitivity and specificity were 100 and 76.5%, respectively.
Discussion
Our study shows that TM is a highly sensitive and specific marker for placental abruption and may have more clinical relevance than traditional markers such as coagulation profile, Kleihauer-Betke fetal red cell screen and ultrasound. TM is a cell surface glycoprotein released from damaged endothelial cells and trophoblast and acts as a cofactor for thrombin, which catalyzes the activation of protein C. Elevated circulating levels of TM have been found in patients with endothelial disorders such as severe preeclampsia, disseminated Fig. 1 Receiver operator characteristic curve comparing sensitivity and false-positive rate for detecting placental abruption at different TM values Table 3 Comparison of sensitivity and specificity of tests This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. intravascular coagulopathy, thrombotic thrombocytopenic purpura and systemic lupus erythematosus (13) . Patients with preeclampsia were excluded from this study as this would be a confounding variable. None of the patients in the study had clinical evidence of DIC before or after their delivery.
The wide distribution of TM on vascular endothelium and in syncytiotrophoblast makes it an ideal marker for placental separation. TM is an acute marker with a relatively short half-life. If there is stabilization of the abruption and organization of the hematoma, TM may not be elevated. This physiology may explain the observation of TM elevation in acute but not in chronic placental abruption.
Microscopically, retroplacental hematomas consist of red cells and fibrin. The amount of fibrin increases as the lesion ages. As the syncytiotrophoblast, vascular endothelium and villous stroma undergo progressive necrosis this is seen histologically as an infarct overlying the hematoma (14) . As the clot and infarct become organized and calcified, the abruption can be readily seen on ultrasound. This pattern was seen in the two subjects with chronic abruption. Patient 7 (see Table 2 ) presented with a 1 month history of vaginal bleeding, severe intrauterine growth retardation and was delivered secondary to fetal decelerations. The placenta revealed 50% infarct with marked intervillous fibrin and clot. Patient 8 presented one month after a motor vehicle accident with fetal decelerations and vaginal bleeding. After delivery, placental histology revealed a 7 ϫ 6 cm placental infarct (10% of its volume).
There were 4 cases of elevated TM who went on to have normal uncomplicated deliveries without evidence of abruption. The vaginal bleeding resolved and there was no clinical evidence of abruption at the time of delivery. They may represent disruptions of the syncytiotrophoblast, which were clinically and pathologically insignificant.
The combination of TM and ultrasound as a "double marker" for abruption detected all cases of abruption. TM may prove useful in the antenatal diagnosis of abruption in the setting of trauma or unexplained vaginal bleeding. The diagnosis of abruption may impact on the clinical monitoring of the fetus as well as on decision-making in the hospitalization and delivery plan. Further studies are ongoing to further elucidate the role of TM as a clinically useful marker in patients at risk for placental abruption.
